Clinical features of hypertrophic pachymeningitis in a center survey
- PMID: 30588552
- DOI: 10.1007/s10072-018-3689-3
Clinical features of hypertrophic pachymeningitis in a center survey
Abstract
Background: Hypertrophic pachymeningitis (HP) is characterized by cranial and/or spinal thickening of the dura mater with or without associated inflammation. Neuroimaging studies reveal dura mater thickening and focal or diffuse contrast enhancement. It is described in association with trauma, infections, tumors, autoimmune/inflammatory diseases, and cerebrospinal fluid hypotension syndrome, with some cases remaining idiopathic.
Methods: A retrospective study was conducted with patients' identification through a key terms search within MRI reports in the period of July 2008 to September 2015. Clinical files, MRI, laboratory, and pathology data were reviewed.
Results: Fifty-three patients were identified and 20 were excluded because they did not meet the inclusion criteria. Of the 33 included, 19 were female, with a mean age at symptoms onset of 51.2 ± 17.6 years. The most common presenting symptoms were headache and cranial nerves palsy, followed by seizures, delirium, lumbar pain, cognitive decline, motor deficit, and language impairment. In 17 patients, a neoplastic etiology was identified; in eight, inflammatory/autoimmune; in six, infectious; and two were classified as idiopathic. Of the eight patients with inflammatory/autoimmune etiology, four had possible IgG4-related disease (IgG4-RD) and the remaining had granulomatosis with polyangiitis, sarcoidosis, rheumatoid arthritis, and Tolosa-Hunt syndrome. Treatment was directed according to the underlying etiology.
Discussion: In the described series, a female predominance was identified, with symptoms' onset in the 5th decade. Although headache was the most common symptom, clinical presentation was varied, emphasizing the role of MRI in HP diagnosis. The underlying etiologies were diverse, with only a few cases remaining idiopathic, also reflecting the contribution of the recently described IgG4-RD.
Keywords: Hypertrophic pachymeningitis; IgG4-related disease; Magnetic resonance imaging; Neurological symptoms.
Similar articles
-
IgG4-related disease and hypertrophic pachymeningitis.Medicine (Baltimore). 2013 Jul;92(4):206-216. doi: 10.1097/MD.0b013e31829cce35. Medicine (Baltimore). 2013. PMID: 23793110 Free PMC article.
-
Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report.Reumatol Clin (Engl Ed). 2023 Jun-Jul;19(6):338-344. doi: 10.1016/j.reumae.2023.05.001. Epub 2023 May 11. Reumatol Clin (Engl Ed). 2023. PMID: 37179159
-
Immune-Mediated Hypertrophic Pachymeningitis and its Mimickers: Magnetic Resonance Imaging Findings.Acad Radiol. 2023 Nov;30(11):2696-2706. doi: 10.1016/j.acra.2023.01.017. Epub 2023 Mar 6. Acad Radiol. 2023. PMID: 36882352 Review.
-
Hypertrophic Pachymeningitis in Chinese Patients: Presentation, Radiological Findings, and Clinical Course.Biomed Res Int. 2020 Aug 14;2020:2926419. doi: 10.1155/2020/2926419. eCollection 2020. Biomed Res Int. 2020. PMID: 32879880 Free PMC article.
-
Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.Autoimmun Rev. 2023 Apr;22(4):103285. doi: 10.1016/j.autrev.2023.103285. Epub 2023 Feb 2. Autoimmun Rev. 2023. PMID: 36738953 Review.
Cited by
-
IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review.Front Neurol. 2022 Sep 15;13:986694. doi: 10.3389/fneur.2022.986694. eCollection 2022. Front Neurol. 2022. PMID: 36188377 Free PMC article.
-
A case report of Immunoglobulin-G4-related hypertrophic sclerosing pachymeningitis.Radiol Case Rep. 2024 Feb 16;19(5):1758-1763. doi: 10.1016/j.radcr.2024.01.079. eCollection 2024 May. Radiol Case Rep. 2024. PMID: 38390429 Free PMC article.
-
Clinical and prognostic profiles in immune-mediated hypertrophic meningitis: a retrospective analysis of 92 cases.Clin Rheumatol. 2025 Jul;44(7):3073-3081. doi: 10.1007/s10067-025-07531-8. Epub 2025 Jun 12. Clin Rheumatol. 2025. PMID: 40504382
-
Hypertrophic Pachymeningitis Associated with Myeloperoxidase-anti-neutrophil Cytoplasmic Antibodies Induced by Propylthiouracil.Intern Med. 2023 Jul 1;62(13):1951-1955. doi: 10.2169/internalmedicine.0692-22. Epub 2022 Nov 16. Intern Med. 2023. PMID: 36384900 Free PMC article.
-
Rapid bilateral visual loss as the initial clinical manifestation in idiopathic hypertrophic cranial pachymeningitis.Clin Case Rep. 2022 May 6;10(5):e05825. doi: 10.1002/ccr3.5825. eCollection 2022 May. Clin Case Rep. 2022. PMID: 35572097 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous